We are live on ! Find out more
Creative Planning

Creative Planning Portfolio holdings

AUM $147B
1-Year Est. Return 18.73%
This Fund
S&P 500
This Quarter Est. Return
+2.62%
1 Year Est. Return
+18.73%
3 Year Est. Return
+48.71%
5 Year Est. Return
+44.71%
10 Year Est. Return
+145.34%
AUM
$29.7B
AUM Growth
+$1.97B
Cap. Flow
+$1.27B
Cap. Flow %
4.28%
Top 10 Hldgs %
54.74%
Holding
2,185
New
207
Increased
867
Reduced
691
Closed
168

Sector Composition

Rank Sector Weight
1 Financials 4.86%
2 Technology 4.06%
3 Healthcare 2.07%
4 Industrials 1.87%
5 Consumer Discretionary 1.87%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AAPL icon
1926
PUT
Apple
AAPL
$4.88T
$7K ﹤0.01%
9,600
-99,600
-91% -$4.85M
MYSZ icon
1927
My Size
MYSZ
$1.96M
$7K ﹤0.01%
3
AVEO
1928
DELISTED
AVEO Pharmaceuticals, Inc.
AVEO
$7K ﹤0.01%
1,050
-3,010
-74% -$25.8K
HD icon
1929
CALL
Home Depot
HD
$330B
$6K ﹤0.01%
300
-200
-40% -$39.9K
LVS icon
1930
CALL
Las Vegas Sands
LVS
$30.4B
$6K ﹤0.01%
1,000
TOPS icon
1931
TOP Ships
TOPS
$4.44M
0
TTD icon
1932
PUT
Trade Desk
TTD
$8.12B
$6K ﹤0.01%
4,000
-6,000
-60% -$129K
HSTO
1933
DELISTED
Histogen Inc. Common Stock
HSTO
$6K ﹤0.01%
110
AGN
1934
CALL
DELISTED
Allergan plc
AGN
$6K ﹤0.01%
700
SDT
1935
DELISTED
SANDRIDGE MISSISSIPPIAN TRUST I
SDT
$6K ﹤0.01%
10,000
-25
-0.2% -$22
MSFT icon
1936
PUT
Microsoft
MSFT
$2.85T
$5K ﹤0.01%
+5,500
New +$698K
ASAP
1937
PUT
DELISTED
Waitr Holdings Inc. Common Stock
ASAP
$5K ﹤0.01%
+500
New +$85.3K
BLRX
1938
BioLineRX
BLRX
$12.7M
$4K ﹤0.01%
17
CCI icon
1939
CALL
Crown Castle
CCI
$32.9B
$4K ﹤0.01%
200
GE icon
1940
CALL
GE Aerospace
GE
$366B
$4K ﹤0.01%
46,126
GILD icon
1941
CALL
Gilead Sciences
GILD
$161B
$4K ﹤0.01%
1,400
HBI
1942
CALL
DELISTED
Hanesbrands
HBI
$4K ﹤0.01%
7,900
META icon
1943
PUT
Meta Platforms (Facebook)
META
$1.53T
$4K ﹤0.01%
+1,200
New +$219K
BA icon
1944
PUT
Boeing
BA
$166B
$3K ﹤0.01%
300
-65,400
-100% -$23.8M
BHC icon
1945
CALL
Bausch Health
BHC
$1.65B
$3K ﹤0.01%
200
IONS icon
1946
CALL
Ionis Pharmaceuticals
IONS
$9.37B
$3K ﹤0.01%
+500
New +$35.3K
IONS icon
1947
PUT
Ionis Pharmaceuticals
IONS
$9.37B
$3K ﹤0.01%
+500
New +$35.3K
QQQ icon
1948
CALL
Invesco QQQ Trust
QQQ
$455B
$3K ﹤0.01%
+300
New +$55.2K
SOXX icon
1949
CALL
iShares Semiconductor ETF
SOXX
$44.3B
$3K ﹤0.01%
+300
New +$19.6K
TRV icon
1950
PUT
Travelers Companies
TRV
$80.6B
$3K ﹤0.01%
2,000

Similar funds

Creative Planning's Q2 2019 Portfolio in Review

As of Q2 2019, Creative Planning held 2,185 positions worth $29.7B, up 7.1% from $27.8B the previous quarter. Its ten largest holdings account for 55% of the portfolio.

Creative Planning deployed $1.27B of net new capital in Q2 2019, opening 207 new positions and adding to 867 existing holdings. Its largest new stake was Dow Inc: 108,999 shares worth $5.38M.

By sector, the portfolio is most concentrated in Financials at 4.9% of assets, up from 4.7% a quarter earlier, followed by Technology and Healthcare.

On the sell side, the largest reduction was Vanguard Mid-Cap ETF, an estimated $115M trimmed.

  • Creative Planning's largest Q2 2019 buy was Dow Inc: 108,999 shares worth $5.38M.
  • Creative Planning added most to iShares Core US Aggregate Bond ETF in Q2 2019, an estimated $297M increase.
  • Creative Planning's biggest Q2 2019 reduction was Vanguard Mid-Cap ETF, cutting an estimated $115M.
  • Creative Planning fully exited Intercept Pharmaceuticals, Inc. in Q2 2019, selling an estimated $3.71M.
  • Creative Planning's ten largest holdings make up 55% of its $29.7B portfolio in Q2 2019.
  • Creative Planning opened 207 new positions and closed 168 in Q2 2019.
  • Creative Planning's portfolio value rose 7.1% quarter-over-quarter to $29.7B.

Based on Creative Planning's 13F filing for Q2 2019, filed 26 Jul 2019.